Abstract # 2318 The Safety and Efficacy of Standard-Dose 90Y Ibritumomab Tiuxetan Combined with High-Dose BEAM and AutologousStem-Cell Transplantation in Patients, Including Those Over 60 Years, with Non-Hodgkin's Lymphoma

Presenter: Krishnan, Amrita

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results

> Conclusions

> View tables/images/videos


Authors:
Krishnan, Amrita (1) ; Nademanee, Auayporn (1) ; Forman, Stephen J (1) ; Fung, Henry (2) ; Molina, Arturo (3) ; Yamauchi, Dave (1) ; Spielberger, Ricardo T (4) ; Kogut, Neil M (4) ; Raubitschek, Andrew (1) .

Institutions:
1. Division of Hematology and Hematopoietic Cell Transplantation , City of Hope
Comprehensive Cancer Center, Duarte, CA, USA.
2.
Hematologic Malignancies, Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Chao Comprehensive Cancer Center, University of California Irvine, Orange, CA, USA.

3.
Global Medical Affairs , Biogen Idec, Inc., San Diego, CA, USA.

4.
Bone Marrow Transplant Program, City of Hope -- Southern California Kaiser Permanente, Duarte, CA, USA.


Click on images to enlarge (a new pop-up window will open)

Title:



E-mail a friend about this abstract:
Enter email address:   





Abstracts main page


Logout